Logo image of IUR.DE

KAP AG (IUR.DE) Stock Fundamental Analysis

FRA:IUR - Deutsche Boerse Ag - DE0006208408 - Common Stock - Currency: EUR

10.4  +0.2 (+1.96%)

Fundamental Rating

2

Overall IUR gets a fundamental rating of 2 out of 10. We evaluated IUR against 15 industry peers in the Industrial Conglomerates industry. IUR has a bad profitability rating. Also its financial health evaluation is rather negative. IUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

IUR had negative earnings in the past year.
In the past year IUR had a positive cash flow from operations.
In the past 5 years IUR reported 4 times negative net income.
In the past 5 years IUR always reported a positive cash flow from operatings.
IUR.DE Yearly Net Income VS EBIT VS OCF VS FCFIUR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

1.2 Ratios

IUR's Return On Assets of -0.12% is on the low side compared to the rest of the industry. IUR is outperformed by 86.67% of its industry peers.
The Return On Equity of IUR (-0.24%) is worse than 86.67% of its industry peers.
Industry RankSector Rank
ROA -0.12%
ROE -0.24%
ROIC N/A
ROA(3y)3.67%
ROA(5y)1.2%
ROE(3y)6.79%
ROE(5y)1.92%
ROIC(3y)N/A
ROIC(5y)N/A
IUR.DE Yearly ROA, ROE, ROICIUR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

IUR's Gross Margin of 55.10% is in line compared to the rest of the industry. IUR outperforms 60.00% of its industry peers.
IUR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for IUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y0.58%
IUR.DE Yearly Profit, Operating, Gross MarginsIUR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

2

2. Health

2.1 Basic Checks

IUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IUR has about the same amount of shares outstanding.
Compared to 5 years ago, IUR has about the same amount of shares outstanding.
The debt/assets ratio for IUR has been reduced compared to a year ago.
IUR.DE Yearly Shares OutstandingIUR.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
IUR.DE Yearly Total Debt VS Total AssetsIUR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that IUR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.15, IUR is doing worse than 86.67% of the companies in the same industry.
IUR has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
IUR has a better Debt to Equity ratio (0.32) than 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC7.19%
IUR.DE Yearly LT Debt VS Equity VS FCFIUR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

IUR has a Current Ratio of 1.49. This is a normal value and indicates that IUR is financially healthy and should not expect problems in meeting its short term obligations.
IUR has a Current ratio of 1.49. This is in the lower half of the industry: IUR underperforms 60.00% of its industry peers.
IUR has a Quick Ratio of 1.49. This is a bad value and indicates that IUR is not financially healthy enough and could expect problems in meeting its short term obligations.
IUR's Quick ratio of 0.89 is on the low side compared to the rest of the industry. IUR is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.89
IUR.DE Yearly Current Assets VS Current LiabilitesIUR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.59% over the past year.
Looking at the last year, IUR shows a very negative growth in Revenue. The Revenue has decreased by -22.26% in the last year.
The Revenue has been decreasing by -2.87% on average over the past years.
EPS 1Y (TTM)78.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.16%
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y1.46%
Revenue growth 5Y-2.87%
Sales Q2Q%91.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IUR.DE Yearly Revenue VS EstimatesIUR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
IUR.DE Yearly EPS VS EstimatesIUR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

IUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IUR.DE Price Earnings VS Forward Price EarningsIUR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IUR.DE Per share dataIUR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.87%, IUR is a good candidate for dividend investing.
IUR's Dividend Yield is rather good when compared to the industry average which is at 3.70. IUR pays more dividend than 100.00% of the companies in the same industry.
IUR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 10.87%

5.2 History

The dividend of IUR decreases each year by -4.67%.
Dividend Growth(5Y)-4.67%
Div Incr Years1
Div Non Decr Years1
IUR.DE Yearly Dividends per shareIUR.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

The earnings of IUR are negative and hence is the payout ratio. IUR will probably not be able to sustain this dividend level.
DP-3183.33%
EPS Next 2YN/A
EPS Next 3YN/A
IUR.DE Yearly Income VS Free CF VS DividendIUR.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

KAP AG

FRA:IUR (3/6/2025, 7:00:00 PM)

10.4

+0.2 (+1.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-21 2024-11-21
Earnings (Next)N/A N/A
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners25.7%
Ins Owner ChangeN/A
Market Cap80.81M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.87%
Yearly Dividend1.54
Dividend Growth(5Y)-4.67%
DP-3183.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF 3.53
P/B 0.52
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.98
FCFYN/A
OCF(TTM)2.94
OCFY28.31%
SpS43.37
BVpS20.03
TBVpS17.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.1%
FCFM N/A
ROA(3y)3.67%
ROA(5y)1.2%
ROE(3y)6.79%
ROE(5y)1.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y0.58%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 78.29%
Cap/Sales 11.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.89
Altman-Z 1.15
F-Score5
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)92.44%
Cap/Depr(5y)77.54%
Cap/Sales(3y)9.53%
Cap/Sales(5y)8.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y1.46%
Revenue growth 5Y-2.87%
Sales Q2Q%91.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1091.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.93%
OCF growth 3Y-30.52%
OCF growth 5Y-2.19%